[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Procept Biorobotics Corp (PRCT)

Procept Biorobotics Corp (PRCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,059,832
  • Shares Outstanding, K 56,919
  • Annual Sales, $ 308,050 K
  • Annual Income, $ -95,570 K
  • EBIT $ -109 M
  • EBITDA $ -103 M
  • 60-Month Beta 0.87
  • Price/Sales 3.33
  • Price/Cash Flow N/A
  • Price/Book 2.95

Options Overview Details

View History
  • Implied Volatility 88.07% (-5.53%)
  • Historical Volatility 61.43%
  • IV Percentile 88%
  • IV Rank 62.81%
  • IV High 112.02% on 07/24/26
  • IV Low 47.62% on 08/28/25
  • Expected Move (DTE 18) 1.11 (5.93%)
  • Put/Call Vol Ratio 0.58
  • Today's Volume 244
  • Volume Avg (30-Day) 271
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 9,130
  • Open Int (30-Day) 11,931
  • Expected Range 17.52 to 19.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.46
  • Number of Estimates 4
  • High Estimate $-0.36
  • Low Estimate $-0.51
  • Prior Year $-0.35
  • Growth Rate Est. (year over year) -31.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.67 +11.58%
on 07/24/26
21.88 -14.99%
on 07/06/26
-2.44 (-11.58%)
since 07/02/26
3-Month
16.67 +11.58%
on 07/24/26
29.74 -37.47%
on 06/09/26
-6.03 (-24.50%)
since 05/01/26
52-Week
16.67 +11.58%
on 07/24/26
51.18 -63.67%
on 08/04/25
-31.36 (-62.78%)
since 08/01/25

Most Recent Stories

More News
Did You Lose Money Investing in PROCEPT BioRobotics Corporation? Contact Robbins LLP for Information About Leading the Class Action Lawsuit Against PRCT

San Diego, California--(Newsfile Corp. - August 3, 2026) - Robbins LLP reminds investors that a securities class action has been filed on behalf of all purchasers of PROCEPT BioRobotics Corporation (NASDAQ:...

PRCT : 18.70 (+0.43%)
PROCEPT BioRobotics Investors: September 22, 2026, Deadline in Securities Fraud Class Action Lawsuit

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

PRCT : 18.70 (+0.43%)
PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT

LOS ANGELES , Aug. 3, 2026 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or "the Company") (NASDAQ: PRCT...

PRCT : 18.70 (+0.43%)
PROCEPT BioRobotics Corporation Securities Fraud Class Action Lawsuit Filed; September 22, 2026, Lead Plaintiff Deadline

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

PRCT : 18.70 (+0.43%)
NASDAQ: PRCT: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against PROCEPT BioRobotics Corporation

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

PRCT : 18.70 (+0.43%)
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK and NEW ORLEANS , July 31, 2026 /PRNewswire/ -- - Kahn Swick & Foti , LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial...

PRCT : 18.70 (+0.43%)
PROCEPT BioRobotics Corporation (PRCT) Investors: September 22, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP

Did you buy PRCT common stock between February 28, 2024 and February 25, 2026? Affected PRCT Investor Summary Who:...

PRCT : 18.70 (+0.43%)
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm Before Lead Plaintiff Deadline on September 22, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BAC : 62.24 (+0.47%)
PRCT : 18.70 (+0.43%)
PROCEPT BioRobotics (PRCT) Faces Securities Class Action Amid Sales Pull-In Concerns - HBSS

SAN FRANCISCO , July 31, 2026 /PRNewswire/ -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) faces a securities class action after repeated surprise unit handpiece sales underperformance and...

PRCT : 18.70 (+0.43%)
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 31, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors...

PRCT : 18.70 (+0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use...

See More

Key Turning Points

3rd Resistance Point 19.92
2nd Resistance Point 19.29
1st Resistance Point 18.96
Last Price 18.70
1st Support Level 18.00
2nd Support Level 17.37
3rd Support Level 17.04

See More

52-Week High 51.18
Fibonacci 61.8% 38.00
Fibonacci 50% 33.92
Fibonacci 38.2% 29.85
Last Price 18.70
52-Week Low 16.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.